Debra Safer MD

Debra Safer MD


Bio:   Dr. Debra L. Safer specializes in the treatment of eating and weight disorders. She obtained her MD from the University of California, San Francisco and completed her residency as well as a post-doctoral fellowship in eating disorder intervention research within the Department of Psychiatry & Behavioral Sciences at Stanford University. She has practiced psychiatry for more than 15 years. Dr. Safer is the Co-Director of the Stanford Adult Eating and Weight Disorders Program. Her research and clinical work in eating disorders and obesity focus on improving patient outcomes by developing and conducting clinical intervention trials to establish evidence-based treatments. She has co-authored multiple peer-reviewed articles, books, and book chapters, and presented her work both nationally and internationally. In addition to her research on clinical interventions and medication trials for patients with eating disorders, other research interests include designing interventions for post-bariatric surgery patients, the use of virtual reality in treating eating disorders, and evaluating the outcomes of evidence-based treatments for eating disorders in “real world” settings. More broadly, she is interested in helping efforts to address climate change mitigation with serial dramas (prosocial entertainment-education programs with methodology based on Dr. Albert Bandura's theories of self-efficacy and social modeling).

Outpatient Psychiatry Clinic

Professional Education

  • Board Certification: Psychiatry, American Board of Psychiatry and Neurology (2000)
  • Internship: Stanford University Medical Center (1995) CA
  • Residency: Stanford University Medical Center (1998) CA
  • Fellowship: Stanford University Medical Center (1999) CA
  • Medical Education: UCSF Medical Center (1994) CA

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.